文献速递乳腺MR

新诊断乳腺癌后术前乳腺MRI用于评估病变范围:一项回顾性队列研究

Preoperative Breast MRI for Extent-of-Disease Evaluation Following New Breast Cancer Diagnosis: A Retrospective Cohort Study.
PubMed 文献 · J Am Coll Radiol · 2025-10-10

本研究回顾性纳入2016年7月1日至2022年12月31日在一家三级多站点学术机构新诊断乳腺癌后接受手术的1792例患者,比较接受(992例)与未接受(800例)术前MRI评估病变范围者的特征。结果显示MRI使用率随年龄、种族、乳腺密度、肿瘤分期、受体状态和组织学类型显著变化,术前MRI与更多全乳切除(49% vs 31%,P < .001)及更少再切除(8% vs 14%,P < .001)相关。作者认为术前MRI通过检出额外病灶改善手术规划并减少再切除需求,但也与更高全乳切除率相关,使用率差异凸显社会人口学和临床差异,强调需针对性努力确保公平可及并制定指南。

要点

  • 术前MRI组49%行全乳切除,未MRI组31%(P < .001),MRI组全乳切除更常见。
  • 术前MRI组8%需再切除,未MRI组14%(P < .001),MRI组再切除率显著更低。
  • 术前MRI者51.5%检出额外可疑病灶,其中69.1%行影像引导活检,26.6%恶性、16.6%高风险。

核心结论

  • 作者认为术前MRI通过检出额外病灶改善手术规划并减少再切除需求,但也与更高全乳切除率相关;使用率随年龄、种族、肿瘤特征和乳腺密度显著变化,凸显社会人口学和临床差异,强调需针对性努力确保公平可及并制定指南。

研究设计与样本

  • 回顾性队列研究,纳入2016年7月1日至2022年12月31日在一家三级多站点学术机构新诊断乳腺癌后接受手术的全部患者1792例,其中行术前MRI评估病变范围者992例、未行者800例,采用χ2检验比较患者特征。

诊断标准与关键数值

  • 年龄≤50岁者MRI使用率77%,51–70岁者50%,>70岁者25%(P < .001)。
  • 白人和其他种族MRI使用率分别为55%和62%,黑人种族为44%(P < .001)。
  • MRI使用率随乳腺密度增加而升高(P < .001),随肿瘤分期升高而升高(P < .001)。
  • Her2+富集疾病患者MRI使用率最高(P < .001),浸润性小叶癌患者使用率也最高(P < .001)。
  • 术前MRI者51.5%检出额外可疑病灶,其中69.1%行影像引导活检,活检结果26.6%恶性、16.6%高风险。

临床应用与阅片要点

  • 作者认为术前MRI通过检出额外病灶改善手术规划并减少再切除需求,但也与更高全乳切除率相关。
  • 作者指出MRI使用率随年龄、种族、肿瘤特征和乳腺密度显著变化,凸显社会人口学和临床差异。
  • 作者强调需针对性努力确保公平可及并制定指南。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Despite potential benefits for surgical planning, prior studies have demonstrated disparities in the use of preoperative breast MRI, raising concerns about equitable access to this imaging tool. In this study, the authors assessed how the rates of preoperative breast MRI use vary by patient sociodemographic and clinical factors and evaluated MRI benefits in this context.

METHODS: This was a retrospective cohort studying including all patients who underwent breast surgery after a new breast cancer diagnosis at a tertiary care multisite academic institution between July 1, 2016, and December 31, 2022 (n = 1,792). Patient characteristics were compared between the patients who did (n = 992) and did not (n = 800) undergo MRI for disease extent evaluation using the χ2 test.

RESULTS: MRI examinations were completed more frequently in patients 50 years or younger and those 51 to 70 years of age compared with those older than 70 years (77% and 50% vs 25%, P < .001) and in those of white and other races than those of black race (55% and 62% vs 44%, P < .001). The rate of MRI increased with increasing breast density (P < .001) and higher tumor stage (P < .001). It was also influenced by receptor status and histology, with the highest utilization in patients with Her2+ enriched disease (P < .001) and those with invasive lobular carcinoma (P < .001). Among patients who underwent preoperative MRI, 51.5% were found to have additional suspicious lesions, and 69.1% of these patients underwent image-guided biopsy (26.6% malignant, 16.6% high risk). Patients who underwent preoperative MRI underwent mastectomy more commonly than those who did not (49% vs 31%, P < .001) but were significantly less likely to require reexcision (8% vs 14%, P < .001).

CONCLUSIONS: The present results suggest that preoperative MRI improves surgical planning by detecting additional lesions and decreasing the need for reexcision but is also associated with higher mastectomy rates. Utilization varied significantly by age, race, tumor features, and breast density, highlighting sociodemographic and clinical disparities. These findings underscore the need for targeted efforts to ensure equitable access and to develop guidelines.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Trinh C, Shi V, Pham T, et al. Preoperative Breast MRI for Extent-of-Disease Evaluation Following New Breast Cancer Diagnosis: A Retrospective Cohort Study. J Am Coll Radiol. 2025. PMID: 41076173. doi:10.1016/j.jacr.2025.10.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。